Category: Diagnostic Health Screenings

A Timeline Of The Lifeline Screening Company

Lifelife Screening is a company that was founded in 1993 in the state of Florida. In 1996, Lifeline Screening begin to expand outside of Florida and began offering its services to the Midwest. Services offered at the Lifeline Screening company were found to be comparable to those offered at medical laboratories at a study done at the University of South Florida in 1998. This proved that Lifeline Screening offers high quality and trusted diagnostic and screening services.

1999, saw Lifeline Screening further expand its screening services across the United States and reach over half a million people with preventive health care. 2002 was another major year for Lifeline Screening. It saw the company screen over 1 million people and be the first major screening company to provide services from the east coast all the way to the west coast and in between. A second study was done at the Cleveland Clinic that also helped prove the validity and accuracy of diagnostic and screening services provided by Lifeline Screening to patients.

In 2005, Lifeline Screening hit another milestone with over three million people receiving screening and preventive healthcare from the company. 2006 saw Lifeline Screening employ over 1000 employees at the company. 2007 was the year the company screened over 5 million people in the United States. 20,000 screening events were also hosted by the company that year. This was also the year that finger-stick blood testing was added to the screening service to test for cholesterol, blood sugar and inflammation. 2007 also saw Lifeline Screening support research initiatives at the National Heart, Lung and Blood Institute and the American Vascular Association.

Lifeline Screening also launched its first screening services in the UK in 2007. 2008 saw the addition of atrial fibrillation to screening procedures. In 2012, Lifeline Screening began screening patients in Australia under a different name called Screen For Life.